Author response for "Development of a CXCR4 antagonistic peptide P12 to suppress pancreatic cancer progress via enhancing T cell responses and sensitizing cells to gemcitabine"Xin Huang, Haiyan Xu, Kui Zhu et al.|Unknown|2025Cited by 0